indantadol drug formerly investigated anticonvulsant neuroprotective development treatment neuropathic pain chronic cough europe vernalis acts competitive reversible nonselective monoamine oxidase low affinity noncompetitive nmda receptor pilot study indantadol chronic cough initiated october april failed achieve significant efficacy neuropathic pain phase iib clinical httpsenwikipediaorgwikiindantadol